BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36944975)

  • 1. Successive onset of Vogt-Koyanagi-Harada syndrome in father and son.
    Li H; Sun S; Zhang Y; Liu J; Zhao X; Zhao G
    BMC Ophthalmol; 2023 Mar; 23(1):113. PubMed ID: 36944975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
    Nakayama M; Keino H; Watanabe T; Okada AA
    Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
    Huang KH; Tai MC; Lee LC; Weng TH; Chen YH; Lin LF; Chen JT; Lu DW; Chen CL
    Medicine (Baltimore); 2018 Mar; 97(9):e0047. PubMed ID: 29489658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China.
    Zhang C; Wang Y; Chen Y; Zhou H; Hong Q; Yu X; Ng TK; Cen LP
    BMC Ophthalmol; 2023 May; 23(1):199. PubMed ID: 37147563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report.
    Koyama M; Nishijima E; Honda T; Gonmori-Ohta C; Sasamoto T; Tanaka K; Watanabe A; Nakano T; Akiyama M
    BMC Ophthalmol; 2024 Mar; 24(1):115. PubMed ID: 38481205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vogt-Koyanagi-Harada syndrome (clinical cases)].
    Sorokin EL; Voronina NV; Avramenko SY; Pomytkina NV
    Vestn Oftalmol; 2015; 131(3):90-98. PubMed ID: 26310014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
    Hamabata K; Hashizume K; Ishikawa Y; Fujiwara T; Machida S; Kurosaka D
    Ocul Immunol Inflamm; 2010 Jan; 18(1):44-5. PubMed ID: 20128649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
    Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
    BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravitreal dexamethasone implant in patients with Vogt-Koyanagi-Harada Disease and bilateral panuveitis: Two case reports.
    Chen PL; Chen SN
    Medicine (Baltimore); 2021 Oct; 100(40):e27394. PubMed ID: 34622843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
    Chew SK; Levy J; Rogers S; Lim LL
    Am J Ophthalmol; 2016 Jul; 167():52-6. PubMed ID: 27066721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
    Arevalo JF; Lasave AF; Gupta V; Kozak I; Al Harbi MB; Al Rushood AA; Al Dhibi HA
    Ocul Immunol Inflamm; 2016 Oct; 24(5):521-9. PubMed ID: 26399962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
    Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
    Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Vogt-Koyanagi-Harada syndrome in 11-year-old girl].
    Swiech-Zubilewicz A; Wróblewska E; Mańkowska A
    Klin Oczna; 2005; 107(7-9):511-4. PubMed ID: 16417010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
    Nakai K; Gomi F; Ikuno Y; Yasuno Y; Nouchi T; Ohguro N; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2012 Jul; 250(7):1089-95. PubMed ID: 22240936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa.
    Khairallah M; Zaouali S; Messaoud R; Chaabane S; Attia S; Ben Yahia S; Hmidi K
    Int Ophthalmol; 2007; 27(2-3):125-30. PubMed ID: 17203358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vogt-koyanagi-harada disease with onset in elderly patients aged 68 to 89 years.
    Yamamoto Y; Fukushima A; Nishino K; Koura Y; Komatsu T; Ueno H
    Jpn J Ophthalmol; 2007; 51(1):60-3. PubMed ID: 17295144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitreous surgery for bilateral bullous retinal detachment in Vogt-Koyanagi-Harada syndrome.
    Gaun S; Kurimoto Y; Komurasaki Y; Yoshimura N
    Ophthalmic Surg Lasers; 2002; 33(6):508-10. PubMed ID: 12449230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.